-
PROVIDERS
Watch now
Are you getting the full picture? A webinar series on the power of comprehensive intelligent diagnostics
-
LIFE SCIENCES
ENROLL NOW
Tempus’ Patient-Derived Organoid ScreensEvaluate the efficacy of your preclinical compounds using fixed organoid panels designed for diverse therapeutic applications.Space is limited — enroll by June 30, 2025, to secure your spot.
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
CARE PATHWAY INTELLIGENCE SOLUTIONS
Tempus Next
An AI-enabled care pathway platform that enables providers to deliver the Next step in a cancer patient’s care journey.
Our Solution
Improve adherence to clinical guidelines through AI-enabled, accurate and targeted notifications at the point of care
Identify and contextualize patients in their care journey
AI-enabled solutions designed to surface deep insights from multimodal, longitudinal patient data including medical imaging data, EHR data, lab results, pathology reports and clinician notes.
Monitor testing rates, treatment patterns and guidelines adoption
Bi-directional site integrations provide life sciences teams with a near-real time data feed of de-identified patient-journey insights.
Increase equitable access to care
Next helps ensure timely and accurate diagnostics, procedures and therapies for all patients, regardless of socioeconomic status.
Figure: In this study, black patients saw a larger decrease in average time from index echo to follow up (120 vs 64 days) compared to white patients (57 to 36 days), showing the improvement in black patients’ time to follow up towards the average seen in white patients’ (narrowing the gap).
Horde G, Sotelo M, D’Amico A, et al. Use of an echocardiographic-based, artificial intelligence system to improve racial disparities in care of patients with valvular heart disease. European Heart Journal – Cardiovascular Imaging. 2023;24(Suppl 1):38.3.
upcoming webinar
Navigating New Frontiers in Breast Cancer Care Pathway Intelligence: The Role of Providers and AI
Learn how Mercy Health System is using Tempus Next to support providers in delivering guideline directed and personalized breast cancer care.
Register nowCase Study
Closing the biomarker testing gap for early stage NSCLC (Non-small cell lung cancer) patients with Tempus NextLearn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
LEARN MORE
Case Study
An algorithmic approach to close care gaps for patients that may benefit from confirmatory IHC HER2 testingLearn how Tempus, in partnership with a global pharmaceutical company, deployed a HER2 predictive algorithm at selected sites within the Tempus network to identify patients who may benefit from additional confirmatory IHC HER2 testing.
LEARN MORE
Webinar
Using AI to identify and close gaps in care for cancer patientsLearn how TriHealth Cancer and Blood institute implemented Tempus Next to accelerate the adoption of precision care pathways for NSCLC patients.
Watch nowImprove adherence to clinical guidelines through AI-enabled and targeted notifications at the point of care.
Trusted by hundreds of biopharma to power drug development
The information on this page is intended for life sciences companies and focuses on research and development applications.
This is data-driven precision medicine
This is the future of healthcare.